{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:04:52Z","timestamp":1788991492719,"version":"build-2803163510"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Psoriasis is a common, chronic, immune-mediated, multisystem, inflammatory disorder. It affects all age groups, including infancy. In one-third of the cases, the onset of the disease is in the first and second decades of life. Childhood psoriasis significantly affects the quality of life of the child as well as that of the entire family. Pediatric psoriasis has distinct clinical presentations and evolves with time. Like in adults, chronic plaque psoriasis has been found to be the most common type of childhood psoriasis. Psoriatic plaques in children are less pruritic, smaller and thinner with less prominent scaling. In pigmented skin, the erythema is less prominent and plaques appear violaceous or hyperpigmented. Pediatric psoriasis can be associated with arthritis, metabolic syndrome, depression and anxiety. Hence all children should be screened routinely for associated comorbidities. Management of pediatric psoriasis is challenging owing to the limitation of approved therapies. 'Proactive therapy' is a recent approach in childhood-onset psoriasis that would help to prevent the severity of flare-ups, thus improving the quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_570_22","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T12:13:57Z","timestamp":1716984837000},"page":"374-380","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Psoriasis in Pediatric Age Group"],"prefix":"10.4103","volume":"67","author":[{"given":"Sandipan","family":"Dhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahana M.","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20240829","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/ijpd.IJPD_111_18","article-title":"Childhood psoriasis: Disease spectrum, comorbidities, and challenges","volume":"20","author":"Sarkar","year":"2019","journal-title":"Indian J Paediatr Dermatol"},{"key":"R2-10-20240829","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R3-10-20240829","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/ijpd.IJPD_86_17","article-title":"A hospitalbased clinical study of childhood psoriasis in a tertiary care center of Northeast India","volume":"19","author":"Das","year":"2018","journal-title":"Indian J Paediatr Dermatol"},{"key":"R4-10-20240829","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/ijpd.IJPD_76_16","article-title":"Clinicoepidemiological study of childhood psoriasis in a tertiary care center","volume":"18","author":"Suganya","year":"2017","journal-title":"Indian J Paediatr Dermatol"},{"key":"R5-10-20240829","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40272-015-0137-1","article-title":"Psoriasis in children and adolescents: Diagnosis, management and comorbidities","volume":"17","author":"Bronckers","year":"2015","journal-title":"Paediatr Drugs"},{"key":"R6-10-20240829","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/ijpd.IJPD_72_18","article-title":"Childhood psoriasis: What is new and what is news","volume":"19","author":"Dogra","year":"2018","journal-title":"Indian J Paediatr Dermatol"},{"key":"R7-10-20240829","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/bjd.14507","article-title":"The epidemiology of childhood psoriasis: A scoping review","volume":"174","author":"Burden-Teh","year":"2016","journal-title":"Br J Dermatol"},{"key":"R8-10-20240829","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1684\/ejd.2016.2932","article-title":"Childhood psoriasis","volume":"26","author":"Mah\u00e9","year":"2016","journal-title":"Eur J Dermatol"},{"key":"R9-10-20240829","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.05.008","article-title":"The current landscape of psoriasis genetics in 2020","volume":"99","author":"Ogawa","year":"2020","journal-title":"J Dermatol Sci"},{"key":"R10-10-20240829","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.3389\/fimmu.2018.02239","article-title":"Clinical and genetic heterogeneity of CARD14 mutations in psoriatic skin disease","volume":"9","author":"Israel","year":"2018","journal-title":"Front Immunol"},{"key":"R11-10-20240829","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaad.2014.10.013","article-title":"Effect of tonsillectomy on psoriasis: A systematic review","volume":"72","author":"Rachakonda","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R12-10-20240829","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaad.2016.06.061","article-title":"HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series","volume":"75","author":"Thorleifsdottir","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R13-10-20240829","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2340\/00015555-2562","article-title":"Patient-reported outcomes and clinical response in patients with moderate-to-severe plaque psoriasis treated with tonsillectomy: A randomized controlled trial","volume":"97","author":"Thorleifsdottir","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"R14-10-20240829","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/postgradmedj-2014-133188","article-title":"Clinical profile of childhood-onset psoriasis and prevalence of HLA-Cw6: A hospital-based study from India","volume":"91","author":"Sathishkumar","year":"2015","journal-title":"Postgrad Med J"},{"key":"R15-10-20240829","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/2319-7250.165638","article-title":"Juvenile generalized pustular psoriasis in a 10-year-old girl","volume":"16","author":"Sharma","year":"2015","journal-title":"Indian J Paediatr Dermatol"},{"key":"R16-10-20240829","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/jid.2015.288","article-title":"Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis vulgaris","volume":"135","author":"Berki","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R17-10-20240829","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10875-017-0399-1","article-title":"Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the first Indian patient and a novel deletion affecting IL1RN","volume":"37","author":"Mendonca","year":"2017","journal-title":"J Clin Immunol"},{"key":"R18-10-20240829","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/pde.13028","article-title":"Nail psoriasis: A systematic evaluation in 313 children with psoriasis","volume":"34","author":"Pourchot","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"R19-10-20240829","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3899\/jrheum.160717","article-title":"CARRA legacy registry investigators. The juvenile psoriatic arthritis cohort in the CARRA registry: Clinical characteristics, classification, and outcomes","volume":"44","author":"Zisman","year":"2017","journal-title":"J Rheumatol"},{"key":"R20-10-20240829","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1525-1470.2008.00676.x","article-title":"Congenital psoriasis: Case report and literature review","volume":"25","author":"Lehman","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R21-10-20240829","doi-asserted-by":"crossref","first-page":"7527859","DOI":"10.1155\/2020\/7527859","article-title":"Atopic dermatitis and psoriasis as overlapping syndromes","volume":"2020","author":"Bozek","year":"2020","journal-title":"Mediators Inflamm"},{"key":"R22-10-20240829","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamadermatol.2017.0499","article-title":"Pediatric psoriasis comorbidity screening guidelines","volume":"153","author":"Osier","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R23-10-20240829","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pde.14208","article-title":"Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: Systematic review and meta-analysis","volume":"37","author":"Phan","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R24-10-20240829","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/ped.13309","article-title":"Pediatric psoriasis: Should we be concerned with comorbidity. Cross-sectional study?","volume":"59","author":"Kelati","year":"2017","journal-title":"Pediatr Int"},{"key":"R25-10-20240829","first-page":"109","article-title":"Psoriatic march, skin inflammation and cardiovascular events \u2013 Two plaques for one syndrome","volume":"33","author":"Boechat","year":"2020","journal-title":"Int J Cardiovasc Sci"},{"key":"R26-10-20240829","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000381913","article-title":"Epidemiology and Comorbidity in children with psoriasis and atopic eczema","volume":"23","author":"Augustin","year":"2015","journal-title":"Dermatology"},{"key":"R27-10-20240829","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaad.2019.08.049","article-title":"Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients","volume":"82","author":"Menter","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R28-10-20240829","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1080\/14656566.2019.1636032","article-title":"Pharmacotherapeutic management of psoriasis in adolescents and children","volume":"20","author":"D\u2019Adamio","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"R29-10-20240829","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/jdv.12789","article-title":"Treatment of paediatric scalp psoriasis with calcipotriene\/betamethasone dipropionate scalp formulation: Effectiveness, safety and influence on children's quality of life in daily practice","volume":"29","author":"Oostveen","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R30-10-20240829","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/pde.13422","article-title":"Use of topical therapies for pediatric psoriasis: A systematic review","volume":"35","author":"Kravvas","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R31-10-20240829","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/pde.13382","article-title":"Pediatric psoriasis: Evolving perspectives","volume":"35","author":"Eichenfield","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R32-10-20240829","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/pde.12632","article-title":"Role of narrowband ultraviolet B phototherapy in the treatment of childhood psoriasis in Asian children","volume":"32","author":"Wong","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"R34-10-20240829","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jdcr.2021.03.038","article-title":"Infantile pustular psoriasis: Case report of successful treatment with acitretin in a 4-week-old infant","volume":"11","author":"Srivatsa","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R35-10-20240829","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/1346-8138.13713","article-title":"Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study","volume":"44","author":"Ergun","year":"2017","journal-title":"J Dermatol"},{"key":"R37-10-20240829","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13555-019-00347-w","article-title":"Systemic treatment of psoriasis with JAK inhibitors: A review","volume":"10","author":"Kvist-Hansen","year":"2020","journal-title":"Dermatol Ther"},{"key":"R38-10-20240829","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.annder.2019.07.005","article-title":"Proactive treatment in childhood psoriasis","volume":"147","author":"Lavaud","year":"2020","journal-title":"Ann Dermatol Venereol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_570_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:45:09Z","timestamp":1787769909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_570_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_570_22","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}